This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Stephen F Previs in Diabetes Treatment
Introduction
Stephen F Previs is an accomplished inventor based in Branchburg, NJ (US). He has made significant contributions to the field of diabetes treatment through his innovative research and development. His work focuses on the use of glucagon receptor antagonists in combination with cholesterol absorption inhibitors.
Latest Patents
Stephen F Previs holds 1 patent for his invention titled "Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor." This patent discloses the use of a glucagon receptor antagonist alongside a cholesterol absorption inhibitor for the treatment of diabetes and related conditions.
Career Highlights
Stephen is currently employed at Merck Sharp & Dohme Corporation, where he continues to advance his research in diabetes treatment. His work has the potential to improve the lives of many individuals suffering from this chronic condition.
Collaborations
Stephen has collaborated with notable colleagues, including Hong-Ping Guan and Jose M Castro-Perez, to further enhance the impact of his research.
Conclusion
Stephen F Previs is a key figure in the innovation of diabetes treatment, with a focus on glucagon receptor antagonists and cholesterol absorption inhibitors. His contributions are paving the way for new therapeutic approaches in managing diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile